Recombinant Vaccines Market Growth, Segmentation, Opportunities, Forecast to 2028

The global recombinant vaccines market size was valued at USD 10.82 billion in 2019 and is projected to reach USD 25.32 billion by 2027, exhibiting a CAGR of 11.3% during the forecast period.

The Recombinant Vaccines Market report contains detailed information on factors influencing demand, growth, opportunities, challenges, and restraints. It provides detailed information about the structure and prospects for global and regional industries. In addition, the report includes data on research & development, new product launches, product responses from the global and local markets by leading players. The structured analysis offers a graphical representation and a diagrammatic breakdown of the The Recombinant Vaccines Market by region.

Get Sample Research PDF:

One of the most crucial and significant drivers for the market growth is the full-fledged advantage of recombinant properties in providing effectiveness and safety to the patient getting immunized.  The vaccines can be produced quickly and in larger quantities, which eliminates the risk of vaccine shortages. These products are also free from infectious viral particles, thus reducing the risk of infection and can be safely given to immunosuppressed people. Owing to the advantages of vaccines, manufacturers are deliberately focused on developing novel products against viral diseases through advanced DNA technology, genomics, and other biotechnology techniques.

Benefits of Purchasing Recombinant Vaccines Market Reports:

  • Customer Satisfaction: Our team of experts assists you with all your research needs and optimizes your reports.
  • Analyst Support: Before or after purchasing the report, ask a professional analyst to address your questions.
  • Assured Quality: Focuses on accuracy and quality of reports.
  • Incomparable Skills: Analysts provide in-depth insights into reports.

Pre-Post COVID-19 Impact on Global Recombinant Vaccines Market

COVID-19 is an infectious disease caused by the most recently discovered novel corona virus. Largely unknown before the outbreak began in Wuhan (China) in December 2019, COVID-19 has moved from a regional crisis to a global pandemic in just a matter of a few weeks.

In addition, production and supply chain delays were also witnessed during the second quarter which poised a challenge to the Recombinant Vaccines Market, since end-user industries were still not operating at their full capacity.

Who are the Major Recombinant Vaccines Market Vendors?

  • GlaxoSmithKline plc. (U.K, Europe)
  • Merck & Co., Inc (New Jersey, U.S)
  • Dynavax Technologies (California, U.S)
  • Pfizer Inc (New York, U.S)
  • Sanofi S.A (France, Europe)
  • Serum Institute of India Pvt. Ltd (India, Asia Pacific)
  • Novartis AG (Switzerland, Europe)
  • Other Prominent Players

In case of any Queries or Customization Requirements please connect with our sales team, who will ensure that your requirements are met.

Ask For Customization:

Secondary Research:

This research study made extensive use of secondary sources, directories, and databases such as Hoover’s, Bloomberg BusinessWeek, Factiva, and OneSource to identify and collect information useful for a technical, market-oriented, and commercial study of the global market. Other secondary sources included company annual reports, press releases, and investor presentations, white papers, certified publications, articles by recognized authors, manufacturer associations, trade directories, and databases.

Primary Research:

Various sources from both the supply and demand sides were interviewed during the primary research process to obtain qualitative and quantitative information for this report. Primary sources included industry experts from the core and related industries, as well as preferred suppliers, manufacturers, distributors, technology developers, researchers, and organizations from all segments of the value chain of this industry. To obtain and verify critical qualitative and quantitative information, in-depth interviews were conducted with a variety of primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants.


Estimation of Market Size

The total size of the Recombinant Vaccines Market was estimated and validated using both top-down and bottom-up approaches. These methods were also widely used to estimate the size of various market sub segments. The following research methodologies were used to estimate market size:

Extensive secondary research was used to identify the industry’s key players.

The revenues generated by the market’s leading players in molecular diagnostics have been determined through primary and secondary research.

All percentage shares, splits, and breakdowns were calculated using secondary sources and confirmed using primary sources.

Speak to Analyst:

North America United States, Canada and Mexico
Europe Germany, UK, France, Italy, Russia and Turkey etc.
Asia-Pacific China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam etc.
South America Brazil, Argentina, Columbia etc.
Middle East & Africa Saudi Arabia, UAE, Egypt, Nigeria and South Africa


  • How big is the Recombinant Vaccines Market?
  • What is Recombinant Vaccines Market?
  • Who is the market leader in Recombinant Vaccines Market?
  • Who are the major players in Recombinant Vaccines Market?
  • What is the future of Recombinant Vaccines Market?
  • What are the fastest growing industries?

Have a Look at Related Report:

Transthyretin Amyloidosis Treatment Market Analysis, Company Profiles, Competitive Landscape and Key Regions, Analysis by 2028

Medical Waste Management Market Size, Analysis, Share, Research, Business Growth and Forecast to 2029

Pediatric Neuroblastoma Treatment Market Revenue, Future Growth, Trends, Top Key Players by 2029

Cervical Cancer Screening Market Top Leading Players with Strategies and Forecast by 2028

Interventional Oncology Market Analysis, Growth Status, Revenue Expectation, Forecast by 2028

Pancreatic Cancer Treatment Market Analysis, Company Profiles, Competitive Landscape and Key Regions, Analysis by 2028

Liver Cancer Treatment Market Size, Analysis, Share, Research, Business Growth and Forecast to 2029

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

Icon Tower, 9th Floor

Baner – Mahalunge Road,

Pune-411045, Maharashtra, India.

Phone: US:+1 424 253 0390,

UK: +44 2071 939123,

APAC: +91 744 740 1245

Email: [email protected]

Carlton Peterson

Carlton is the contributing author of electronic security. His field of communication is fascinating since he writes about that side of the industry which is costly, less used but more inclined upon by developed countries. Electronic securities have been seeing an upward graph nowadays, but the current scenario still needs to be changed. Carlton’s articles reflect the real happening wrapped up in formally written words.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *